Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECTS OF ACTIVATED FACTOR-VII IN A CELL-BASED MODEL FOR TISSUE FACTOR-INITIATED COAGULATION, Blood coagulation & fibrinolysis, 9, 1998, pp. 21-25
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
ROBERTS HR
Citation: M. Kjalke et al., ACTIVE SITE-INACTIVATED FACTORS VIIA, XA, AND IXA INHIBIT INDIVIDUAL STEPS IN A CELL-BASED MODEL OF TISSUE FACTOR-INITIATED COAGULATION, Thrombosis and haemostasis, 80(4), 1998, pp. 578-584
Authors:
HANSEN K
KJALKE M
RASMUSSEN PB
KONGERSLEV L
EZBAN M
Citation: K. Hansen et al., PROTEOLYTIC CLEAVAGE OF RECOMBINANT 2-CHAIN FACTOR-VIII DURING CELL-CULTURE PRODUCTION IS MEDIATED BY PROTEASE(S) FROM LYSED CELLS - THE USE OF PULSE LABELING DIRECTLY IN PRODUCTION MEDIUM, Cytotechnology, 24(3), 1997, pp. 227-234
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
ROBERTS HR
Citation: M. Kjalke et al., COMPARISON OF THE EFFECTS OF ACTIVE SITE-INHIBITED FACTORS VIIA, XA, AND IXA IN A CELL-BASED MODEL FOR TISSUE FACTOR INITIATED COAGULATION, Thrombosis and haemostasis, 1997, pp. 40-40
Authors:
KJALKE M
OLIVER JA
MONROE DM
HOFFMAN M
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECT OF ACTIVE SITE-INHIBITED FACTOR VIIA ON TISSUE FACTOR-INITIATED COAGULATION USING PLATELETS BEFORE AND AFTER ASPIRIN TREATMENT, Thrombosis and haemostasis, 1997, pp. 44-44
Authors:
KJALKE M
OLIVER JA
MONROE DM
HOFFMAN M
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECT OF ACTIVE SITE-INHIBITED FACTOR VIIA ON TISSUE FACTOR-INITIATED COAGULATION USING PLATELETS BEFORE AND AFTER ASPIRIN ADMINISTRATION, Thrombosis and haemostasis, 78(4), 1997, pp. 1202-1208
Authors:
SORENSON BB
PERSSON E
FRESKGARD PO
KJALKE M
EZBAN M
WILLIAMS T
RAO LVM
Citation: Bb. Sorenson et al., INCORPORATION OF AN ACTIVE-SITE INHIBITOR IN FACTOR VIIA ALTERS THE AFFINITY FOR TISSUE FACTOR (VOL 272, PG 11863, 1997), The Journal of biological chemistry, 272(26), 1997, pp. 16708-16708
Authors:
SORENSEN BB
PERSSON E
FRESKGARD PO
KJALKE M
EZBAN M
WILLIAMS T
RAO LVM
Citation: Bb. Sorensen et al., INCORPORATION OF AN ACTIVE-SITE INHIBITOR IN FACTOR VIIA ALTERS THE AFFINITY FOR TISSUE FACTOR, The Journal of biological chemistry, 272(18), 1997, pp. 11863-11868
Authors:
KJALKE M
OLIVER JA
MONROE DM
HOFFMAN M
EZBAN M
ROBERTS HR
HEDNER U
Citation: M. Kjalke et al., THE EFFECT OF ACTIVE SITE-INHIBITED COAGULATION-FACTOR VIIA ON TISSUEFACTOR-INITIATED COAGULATION USING PLATELETS BEFORE AND AFTER ASPIRINTREATMENT, Blood, 88(10), 1996, pp. 2996-2996
Authors:
WEGENER KM
KJALKE M
ELM T
KRISTENSEN AT
RASMUSSEN K
BREGENGARD C
Citation: Km. Wegener et al., TISSUE FACTOR-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN RABBITS - THE EFFECT ON BLEEDING-TIME AND BLOOD-LOSS, Thrombosis and haemostasis, 73(6), 1995, pp. 1434-1434
Authors:
KJALKE M
HEDING A
TALBO G
PERSSON E
THOMSEN J
EZBAN M
Citation: M. Kjalke et al., AMINO-ACID-RESIDUES 721-729 ARE REQUIRED FOR FULL FACTOR-VIII ACTIVITY, European journal of biochemistry, 234(3), 1995, pp. 773-779
Citation: M. Kjalke et al., STRUCTURAL-ANALYSIS OF CHICKEN FACTOR-B-LIKE PROTEASE AND COMPARISON WITH MAMMALIAN COMPLEMENT PROTEINS FACTOR-B AND C2, The Journal of immunology, 151(8), 1993, pp. 4147-4152
Authors:
PLOUG M
KJALKE M
RONNE E
WEIDLE U
HOYERHANSEN G
DANO K
Citation: M. Ploug et al., LOCALIZATION OF THE DISULFIDE BONDS IN THE NH2-TERMINAL DOMAIN OF THECELLULAR RECEPTOR FOR HUMAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - A DOMAIN-STRUCTURE BELONGING TO A NOVEL SUPERFAMILY OF GLYCOLIPID-ANCHORED MEMBRANE-PROTEINS, The Journal of biological chemistry, 268(23), 1993, pp. 17539-17546
Citation: M. Kjalke et al., FUNCTION OF RECOMBINANT FACTOR-VIII WITH HEAVY-CHAIN CONSISTING OF AMINO-ACID 1-740, 1-729 AND 1-720, Blood, 82(10), 1993, pp. 10000060-10000060